Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of these medicinal products is substantial. |
Clinical Added Value
| no clinical added value |
PECFENT does not provide any improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of break through pain in adult patients who take morphine drugs to treat chronic cancer pain. |
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
UWe0k8xrAUM8xbWW
